Kočka V - Search Results

1

Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease.

Krackhardt F, Waliszewski M, Kočka V, Toušek P, Janek B, Hudec M, Lozano F, Roman KG, Del Blanco BG, Mauri J, Heang TM, Ahn TH, Jeong MH, Herberger D, Tomulic V, Levy G, Sebagh L, Rischner J, Pansieri M. Krackhardt F, et al. Among authors: kocka v. Cardiovasc Drugs Ther. 2022 Dec;36(6):1257-1258. doi: 10.1007/s10557-021-07290-z. Cardiovasc Drugs Ther. 2022. PMID: 35867320 Free PMC article. No abstract available.

2

High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel.

Osmancik P, Paulu P, Tousek P, Kocka V, Widimsky P. Osmancik P, et al. Among authors: kocka v. J Thromb Thrombolysis. 2012 May;33(4):349-54. doi: 10.1007/s11239-011-0659-5. J Thromb Thrombolysis. 2012. PMID: 22189756 Clinical Trial.

3

Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease.

Paulu P, Osmancik P, Tousek P, Minarik M, Benesova L, Motovska Z, Bednar F, Kocka V, Widimsky P. Paulu P, et al. Among authors: kocka v. J Thromb Thrombolysis. 2013 Jul;36(1):1-6. doi: 10.1007/s11239-012-0813-8. J Thromb Thrombolysis. 2013. PMID: 23054463 Clinical Trial.

4

ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases.

Kočka V, Lisa L, Toušek P, Buděšínský T, Widimský P. Kočka V, et al. Eur Heart J. 2013 Jul;34(27):2073. doi: 10.1093/eurheartj/eht168. Epub 2013 May 31. Eur Heart J. 2013. PMID: 23729688 No abstract available.

5

Pharmacodynamic effect of clopidogrel in patients undergoing transcatheter aortic valve implantation.

Tousek P, Kocka V, Sulzenko J, Bednar F, Linkova H, Widimsky P. Tousek P, et al. Among authors: kocka v. Biomed Res Int. 2013;2013:386074. doi: 10.1155/2013/386074. Epub 2013 Jul 15. Biomed Res Int. 2013. PMID: 23956980 Free PMC article.

6

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'.

Kočka V, Malý M, Toušek P, Buděšínský T, Lisa L, Prodanov P, Jarkovský J, Widimský P. Kočka V, et al. Eur Heart J. 2014 Mar;35(12):787-94. doi: 10.1093/eurheartj/eht545. Epub 2014 Jan 12. Eur Heart J. 2014. PMID: 24419808 Free PMC article. Clinical Trial.

7

[Fully absorbable drug eluting coronary stent: where do we stand in 2014?].

Kočka V, Toušek P, Lisa L, Buděšínský T. Kočka V, et al. Vnitr Lek. 2014 Apr;60(4):322-6. Vnitr Lek. 2014. PMID: 24985992 Review. Czech.

8

Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.

Toušek P, Kočka V, Malý M, Lisa L, Buděšínský T, Widimský P. Toušek P, et al. Among authors: kocka v. Heart Vessels. 2016 Jun;31(6):841-5. doi: 10.1007/s00380-015-0679-8. Epub 2015 Apr 21. Heart Vessels. 2016. PMID: 25896128

9

Transcatheter aortic valve implantation: long-term clinical outcome and valve durability.

Sulzenko J, Tousek P, Kocka V, Widimsky P. Sulzenko J, et al. Among authors: kocka v. Expert Rev Med Devices. 2015;12(5):529-35. doi: 10.1586/17434440.2015.1063994. Epub 2015 Jul 3. Expert Rev Med Devices. 2015. PMID: 26134100

10

Absorb bioresorbable stents for the treatment of coronary artery disease.

Kočka V, Toušek P, Widimský P. Kočka V, et al. Expert Rev Med Devices. 2015;12(5):545-57. doi: 10.1586/17434440.2015.1080119. Expert Rev Med Devices. 2015. PMID: 26305838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters